+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Virological evaluation of zidovudine azt treatment in hiv infected subjects

Virological evaluation of zidovudine azt treatment in hiv infected subjects

Bollettino Societa Italiana Biologia Sperimentale 66(6): 601-606

The authors report preliminary results of the virological evaluation (performed by serum p24 antigen detection and HIV isolation from peripheral blood lymphocytes) of Zidovudine therapy in 64 anti-HIV positive subjects. Data presented indicate that the administration of therapeutic doses of the drug can efficiently and precociously inhibit viral replication, suggesting that the clinical benefits of the therapy may be related to the anti-viral activity of the drug. However, the anti-viral efficacy of Zidovudine seems to be of limited length; in fact a reactivation of viral replication was observed in most patients during the study.

(PDF emailed within 1 workday: $29.90)

Accession: 007999982

Download citation: RISBibTeXText

Related references

Virological monitoring in subjects with HIV infection under treatment with zidovudine (AZT). Bollettino Della Societa Italiana di Biologia Sperimentale 66(6): 601-606, 1990

Immunological and virological parameters in a double blind placebo controlled study of zidovudine zdv treatment in hiv 1 infected asymptomatic homosexual men. Viii International Conference on Aids And The Iii Std World Congress Viii International Conference on Aids And The Iii Std World Congress; Harvard-Amsterdam Conference, Amsterdam, Netherlands, July 19-24, Pagination Varies Viii International Conference on Aids And The Iii Std World Congress: Amsterdam, Netherlands Paper : b166, 1992

Zidovudine treatment of asymptomatic hiv infected subjects. Journal of Cellular Biochemistry Supplement (13 PART B): 302, 1989

Nevirapine/zidovudine/lamivudine has superior immunological and virological responses not reflected in clinical outcomes in a 48-week randomized comparison with abacavir/zidovudine/lamivudine in HIV-infected Ugandan adults with low CD4 cell counts. HIV Medicine 11(5): 334-344, 2010

Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects. Antiviral Research 13(3): 127-138, 1990

Long term treatment with zidovudine with or without acyclovir of asymptomatic hiv 1 infected subjects. Sixth International Conference on Aids Sixth International Conference on Aids, Vols 1-3 Pagination Varies Sixth International Conference on Aids University Of California San Francisco: San Francisco, California, Usa Illus Maps Paper : abstract Sb449, 1990

Absence of zidovudine resistance in antiretroviral-naive patients following zidovudine/lamivudine/protease inhibitor combination therapy: virological evaluation of the AVANTI 2 and AVANTI 3 studies. Aids 14(9): 1195-1201, 2000

Immunological and virological status of an htlv 1 infected arc patient treated with zidovudine. Journal of Cellular Biochemistry Supplement (14 PART D): 135, 1990

Serum beta microglobulin levels in asymptomatic hiv 1 infected subjects during long term zidovudine treatment. Genitourinary Medicine 67(3): 188-193, 1991

Disease progression despite antigen decline during zidovudine treatment of asymptomatic hiv infected subjects need for placebo controlled trials. Morisset, R A (Ed ) Ve Conference Internationale Sur Le Sida: Le Defi Scientifique Et Social; V International Conference on Aids: The Scientific And Social Challenge; Montreal, Quebec, Canada, June 4-9, 1262p International Development Research Centre: Ottawa, Ontario, Canada Illus Paper 280, 1989

Effect of early treatment with zidovudine on progression to AIDS and on survival in HIV infected subjects, depending on their degree of immunodeficiency. IXTH INTERNATIONAL CONFERENCE ON AIDS AND THE IVTH STD WORLD CONGRESS [Author] IXth International Conference on AIDS in affiliation with the IVth STD World Congress : 474, 1993

Early virological response of zidovudine/lamivudine/abacavir for patients co-infected with HIV and tuberculosis in Uganda. Aids 21(14): 1972-1974, 2007

Virological response after short-term CCR5 antagonist exposure in HIV-infected patients: frequency of subjects with virological response and associated factors. Antimicrobial Agents and ChemoTherapy 55(10): 4664-4669, 2012